Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer-Reference-Cited by-同舟云学术

Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer

Published:2019-05-06 Issue:6 Volume:19 Page:3527-3534
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Chen Xinli¹,Zhou Wenxi¹,Liang Chen²³,Shi Si²³,Yu Xianjun²³,Chen Qinjun¹,Sun Tao¹,Lu Yifei¹,Zhang Yujie¹,Guo Qin¹,Li Chao¹,Zhang Yu¹,Jiang Chen¹^ORCID

Affiliation:

1. Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Medical Neurobiology, Research Center on Aging and Medicine, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China

2. Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai 200032, China

3. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.9b00374

Reference36 articles.

1. Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial

2. Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer

3. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

2. Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications;International Journal of Nanomedicine;2024-07

3. Unleashing a Dual‐Warhead Nanomedicine to Precisely Sensitize Immunotherapy for Pancreatic Ductal Adenocarcinoma;Advanced Functional Materials;2024-03-21

4. Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer;International Journal of Nanomedicine;2024-03

5. Acidic tumor microenvironment-activated MRI nanoprobes for modulation and visualization of anti-PD-L1 immunotherapy;Nano Today;2024-02